MY PURE PEPTIDE IPAMORELIN 10MG

Ipamorelin 10 mg — Selective GHRP-Class Peptide for GH Secretion Research

Ipamorelin is a synthetic pentapeptide classified as a
growth hormone–releasing peptide (GHRP)-type analog. It is investigated in
preclinical and exploratory clinical research as a selective growth hormone
secretagogue with reduced off-target activity at receptors such as ACTH and cortisol
pathways, compared with earlier GHRPs.

What It Is

• Class: GHRP-class growth hormone secretagogue
• Peptide length: 5 amino acids (pentapeptide)
• Research focus: Pituitary GH release, GH/IGF-1 axis behavior, and
  combination protocols with GHRH analogs.

Proposed Mechanisms (Preclinical)

Selected Research Highlights

• GH Secretion: Ipamorelin has been studied for its ability to
  increase GH in a pulsatile fashion, with interest in a more selective side-effect
  profile versus earlier GHRP compounds.
• Endocrine Selectivity: Experimental and early clinical data examine
  ACTH, cortisol, and prolactin responses to characterize its endocrine selectivity.
• Body-Composition & Recovery Models: Research in animals and
  small human cohorts has explored markers of body composition, strength, and recovery,
  typically as exploratory endpoints.

Chemical & Handling Information

• Type: Synthetic GHRP-class pentapeptide
• Appearance: White to off-white lyophilized powder

Specifications

• Peptide: Ipamorelin
• Amount: 10 mg per vial
• Form: Lyophilized powder
• Purity: ?99% (HPLC); COA per lot available
• Packaging: Sealed vials suitable for standard laboratory handling